INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Community-First Approach To Drive Diversity In Clinical Research
Community-based clinical trials enhance diversity, addressing mistrust and access barriers by fostering local partnerships and accessible trial sites for underrepresented communities.
-
AI-Powered Strategy Is Redefining Patient Recruitment Performance
This AI-powered platform is helping CROs and sponsors tackle the unsolved challenge they've faced for decades: clinical trials that launch late, recruit slowly, and miss enrollment targets.
-
Early Phase Oncology Site Network: Benefits Of A Personal Touch
Choose a site network built on partnership — not volume — to drive smoother early-phase oncology trials and deliver better outcomes for sponsors, sites, and patients.
-
Hybrid Ophthalmic Trials: Splitting Visits Across Home, Hub, And Site
Hybrid ophthalmic trials combine in-person and remote visits, boosting patient convenience, reducing site burden, and accelerating timelines while maintaining data quality and compliance.
-
Enhancing Participant Payments: A New Approach10/30/2024
Managing participant payments in clinical trials is a multifaceted challenge impacting participants, sites, and sponsors alike. Delve into the intricacies and numerous hurdles faced in this process.
-
Central eSource Is The Latest In Sponsor Provided Site Offerings7/7/2025
For decades, sponsors have provided tools to help clinical sites work more efficiently. Central eSource is the latest evolution in this trend.
-
Rescuing A Global Program For NDA Success8/12/2025
Explore the collaboration that enabled FDA approval of a novel chronic-condition therapy, rescued a high-risk program, and demonstrated a unified “one-team” approach by reworking the sponsor's SAP.
-
Built For Sites To Benefit All7/15/2024
This one-minute video highlights the benefits of One Home for Sites. Join the movement to increase clinical trial capacity, because patients are waiting.
-
How Real-World Data On Site Costs Accelerates Clinical Trial Success10/23/2025
Outdated budgeting slows oncology trials. Real-world site cost data enables faster planning, smoother startup, and better patient care through smarter, evidence-based financial decisions.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Novotech’s Regulatory Affairs team offers customized, end-to-end clinical and regulatory solutions, guiding biotechnology, pharmaceutical, and medical device companies through the entire product lifecycle.
-
Generate accurate study budgets faster with the industry’s most contemporary fair market value (FMV) data for investigator grant costs based on real-world site costs.
-
Traditional clinical trial models can create financial burden by neglecting participant needs – but effective use of stipends can allow participants to fully engage without financial worries.
-
Making it easier to participate in and run clinical trials with simplified patient scheduling and appointment reminders.
-
Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes, and relatively high costs.